Manijeh Beigi | Medical Physics | Best Researcher Award

Posted on by sciencefather

Dr. Manijeh Beigi | Medical Physics | Best Researcher Award

Dr. Manijeh Beigi is an Assistant Professor in the Radiation Oncology Department at Iran University of Medical Sciences. She specializes in dosimetry, radiotherapy treatment planning, and quality audits, with a focus on using machine learning for radiomics and dosiomics analysis. Dr. Beigi earned her Ph.D. in Medical Physics from Tehran University of Medical Sciences in 2018, where she researched the application of Diffusion Tensor Imaging (DTI) in radiotherapy planning. With over a decade of experience in radiotherapy physics, she has worked in multiple hospitals, including Imam Hosein, Haft-e-Tir, and Pardis Niloo Cancer Center. She is actively involved in research on predicting radiotherapy toxicity and advanced MR imaging applications. Dr. Beigi has mentored numerous students, contributed to high-impact journals, and presented at international conferences. Her research aims to enhance radiotherapy precision and patient safety through cutting-edge imaging and AI-driven models. 🎓🔬

Profile

Education 🎓

Dr. Manijeh Beigi holds a Ph.D. in Medical Physics (2018) from Tehran University of Medical Sciences, where she developed automated clinical target volume determination for glioma treatment using multiparametric MRI. She completed her M.Sc. in Medical Physics (2010) at Tarbiat Modares University, focusing on radiotherapy dosimetry and quality audits in Varian linear accelerators. Her coursework covered key topics such as radiotherapy physics, radiobiology, MRI, CT, and PET physics, statistical methods, and treatment planning. Throughout her academic journey, she has specialized in advanced imaging techniques, radiomics, and AI-based predictive modeling for radiotherapy applications. Dr. Beigi’s education has provided her with strong expertise in medical physics, treatment planning optimization, and quality assurance, positioning her as a leader in radiation oncology research and innovation. 📚

Experience 👨‍🏫

Dr. Manijeh Beigi has been an Assistant Professor at Iran University of Medical Sciences since 2020, where she focuses on radiotherapy physics, treatment planning, and quality assurance. Previously, she worked as a Radiotherapy Physicist at Imam Hosein Hospital (2010-2016), Haft-e-Tir Hospital (2016-Present), and Pardis Niloo Cancer Center (2019-2021), specializing in 3D conformal radiotherapy, IMRT planning, machine QA, and dosimetry. She was also a Research Assistant (2012-2018) at Tehran University of Medical Sciences, collaborating on quantitative MRI and spectroscopy research. Dr. Beigi has significant experience in mentoring students, managing research projects, and implementing AI-driven radiotherapy solutions. Her work integrates imaging and machine learning to optimize treatment efficacy and minimize patient toxicity. 💼🔬

Research Interests 🔬

Dr. Manijeh Beigi’s research centers on dosimetry, radiotherapy quality audits, and the application of machine learning in radiomics and dosiomics. She explores AI-driven models to predict radiotherapy toxicity and optimize treatment planning. Her work integrates advanced MRI techniques, such as Diffusion Tensor Imaging (DTI), to enhance clinical target volume delineation for gliomas and other cancers. She investigates imaging biomarkers to assess radiation-induced damage and improve treatment precision. Additionally, Dr. Beigi is actively involved in multi-disciplinary research collaborations, utilizing deep learning for medical image analysis. Her contributions aim to advance radiation oncology by improving accuracy, reducing side effects, and personalizing treatment plans. 🧬📡

Dr. Manijeh Beigi has received several accolades for her contributions to medical physics and radiotherapy research. She has been recognized for her work in AI-driven radiomics and dosiomics at international conferences, including ESTRO and AAPM. Her research on glioma segmentation using DTI and radiotherapy toxicity prediction has been published in top-tier journals. She has also been awarded grants for her studies on advanced MRI applications in radiotherapy planning. Additionally, Dr. Beigi has played a key role in multi-institutional research collaborations, earning recognition for her leadership in medical imaging and quality assurance. 🏆🎖️

Publications 📚

Kawthar Diab | Biology and Life Science | Best Researcher Award

Posted on by sciencefather

Prof Dr. Kawthar Diab | Biology and Life Science | Best Researcher Award

 

Profile

Education

She holds a Ph.D. in Zoology from Ain Shams University, awarded in March 2009, with her research focusing on the protective role of medicinal plants against the genotoxic effects induced by hydrocortisone in mice. Prior to that, she earned an M.Sc. in Experimental Zoology from Zagazig University in May 2003, where she conducted cytogenetic and immunogenetic studies on cisplatin and 5-fluorouracil, with a particular focus on their effects on reproduction in rats. She completed her B.Sc. in Zoology from Al-Azhar University in May 1996, graduating with a “very good” grade. Her postdoctoral research includes a six-month fellowship at Tokai University, Japan, in the Department of Bioscience, School of Agriculture, from June to December 2014. Additionally, she pursued another six-month postdoctoral fellowship in the Cancer Pharmacology Division at the Indian Institute of Integrative Medicine, Jammu, India, from March to September 2012.

Work experience

She has actively participated in international workshops and conferences, including the Fluorescence Microscopy workshop “FluoMicro@ICGEB” at the International Center for Genetic Engineering and Biotechnology (ICGEB) in New Delhi, India, from October 2nd to 4th, 2019. Additionally, she was a speaker at the 6th Rajabhat University National and International Research and Academic Conference, held virtually on August 17-18, 2020, where she presented her research on the Cancer Chemopreventive Activity of Himalayan Plants. In terms of academic supervision, she has guided Ph.D. student Amr Mohammed Abo-Elhamd Ahmed, an Assistant Researcher at the Department of Aromatic and Medicinal Plants, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Cairo, Egypt. His research focuses on the biochemical and therapeutic evaluation of selected Lamiaceae family plants for prostate disease treatment.

Research project

She has actively contributed to several local and international research projects, playing key roles in various studies. From 2005 to 2008, she was a member of a National Research Centre (NRC) project investigating the genotoxic effects of environmental pollution and veterinary drugs (Project No. 7110613). Between 2010 and 2013, she participated in an NRC-funded project on the production and evaluation of bioactive metabolites and hypolipidemic agents derived from marine sponge and coral endophytic microorganisms against carcinogenic pathogens, liver, and colon cancer (Project No. 9100302).

Her research extended to environmental toxicology, where she contributed to a Science & Technology Development Fund (STDF) project (2012-2014) evaluating mango byproducts as antioxidants against genetic damage caused by lead pollution (Project No. 4782). From 2017 to 2019, she served as a Co-Principal Investigator (Co-PI) on an NRC project studying the anti-hepatotoxic and antigenotoxic properties of plant extracts and their safety for use (Project No. 11010345). During the same period, she was also a member of an NRC project exploring the effects of nanoparticles in tissue culture applications (Project No. 11030108).

Her expertise further contributed to projects applying OMICS technology to enhance food safety in Egypt (2020-2022, Project No. 12050305) and exploring new pharmaceutical raw materials for prostate disease treatment (2020-2022, Project No. 12060108). Additionally, she collaborated with the Bulgarian Academy of Sciences on a research project (2020-2022) focused on improving the production of therapeutic ingredients in Lamiaceae plants for prostate disease treatment using biotechnology techniques.

Publication

 

  • Zaied FA, Zabal M, Diab KA (2003): Cytogenetic and Imuunogenetic studies of cisplatin and 5-Fluorouracil in rats. Zagazig University Journal, (IX):133–156.
  • Fahmy MA,Diab KA (2009): In vivo genotoxicity studies of cefotaxime.Cytologia, 74 (4):417–425.
  • Diab KA, Hassan ZM. (2011): Assessment of the antigenotoxic activity of white sesame extract (Sesamum indicum) against vincristine induced genotoxicity in mice. Comunicata Scientiae, 2(3)126-134.
  • Diab KA and Aboul-Ela E I (2012): In vivo comparative studies on antigenotoxicity of date palm (Phoenix dactylifera L.) pits extract against DNA damage induced by N-Nitroso-N-methylurea in mice. Toxicology International, 19 (3):279-286.
  • Diab KA,Elmakawy AI, Abd El-Moneim OM, Sharaf HA (2012): Assessment of genotoxicity and histopathological changes induced by polyethylene glycol (PEG 6000) in male mice.  Journal of Cytology & Histology, 3(5): 153.
  • Khalil WKB, Ghal IS, Diab KA,Elmakawy AI (2014): Antitumor activity of Moringaoleifera leaf extract against Ehrlich solid tumor. International Journal of Pharmacy, 4(3): 68-82.
  • Elmakawy AI, Abd El-Moneim OM, Diab KA,Sharaf HA (2014) Evaluation of male-mediated reproductive toxicity induced by polyethylene glycol in mice. World Applied Sciences Journal, 31 (8): 1478-1487.